PHOBIA - PREVALENCE AND RISK-FACTORS

被引:95
|
作者
BOYD, JH
RAE, DS
THOMPSON, JW
BURNS, BJ
BOURDON, K
LOCKE, BZ
REGIER, DA
机构
[1] NIMH,DIV CLIN RES,ROOM 10-C-09,PARKLAWN BLDG,5600 FISHERS LANE,ROCKVILLE,MD 20857
[2] NIMH,DIV BIOMETRY & APPL SCI,ROCKVILLE,MD 20857
关键词
D O I
10.1007/BF00782887
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This article is the presentation of the main phobia data from the Epidemiologic Catchment Area (ECA) program, with a sample size of n=18,571. Work on this article was initiated in 1981 at the beginning of the ECA study, but publication has been delayed a decade. Phobias are determined from information from the Diagnostic Interview Schedule (DIS), classified according to DSM III. Phobias are found to be the most common psychiatric disorder in the community, more common than major depression or alcohol abuse or dependence in the month prior to interview. The one month prevalence is between 4.0 and 11.1%, with the estimated prevalence in the United States being 6.2%. There were nine community surveys of the prevalence of phobia that pre-dated the ECA studies, which found a wide range of prevalence rates from 1.2% to 26.1%. By far the strongest risk factor associated with phobias is the presence of another psychiatric disorder. Prevalence rates of simple phobia and agoraphobia are found in the ECA studies to be significantly higher in women; social phobia, which is less prevalent, has no significant sex difference. The prevalence rates are higher in younger age groups, and in those with low socioeconomic status (SES). The onset of phobias occurs primarily in the childhood or teenage years, and they tend to be chronic conditions. Less than a quarter of phobics receive treatment. © 1990 Springer-Verlag.
引用
收藏
页码:314 / 323
页数:10
相关论文
共 50 条
  • [1] Specificity of family risk-factors for the onset and course of social phobia
    Knappe, S.
    Beesdo-Baum, K.
    Lieb, R.
    Wittchen, H. U.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2011, 21 : S532 - S533
  • [2] PERIMENSTRUAL SYMPTOMS - PREVALENCE AND RISK-FACTORS
    LOGUE, CM
    MOOS, RH
    [J]. PSYCHOSOMATIC MEDICINE, 1986, 48 (06) : 388 - 414
  • [3] STUDY OF PREVALENCE OF CARDIOVASCULAR RISK-FACTORS
    DELULUAGA, IY
    DEMAZZUCCO, OS
    KIRZNER, T
    BARMAT, R
    LAJFER, J
    PLOTQUIN, Y
    [J]. PRENSA MEDICA ARGENTINA, 1984, 71 (01): : 15 - 23
  • [4] ESOPHAGITIS IN SCLERODERMA - PREVALENCE AND RISK-FACTORS
    ZAMOST, BJ
    HIRSCHBERG, JM
    IPPOLITI, AF
    FURST, DE
    CLEMENTS, PJ
    WEINSTEIN, WM
    [J]. CLINICAL RESEARCH, 1982, 30 (01): : A40 - A40
  • [5] ESOPHAGITIS IN SCLERODERMA - PREVALENCE AND RISK-FACTORS
    ZAMOST, BJ
    HIRSCHBERG, J
    IPPOLITI, AF
    FURST, DE
    CLEMENTS, PJ
    WEINSTEIN, WM
    [J]. GASTROENTEROLOGY, 1987, 92 (02) : 421 - 428
  • [6] INTERMITTENT CLAUDICATION - PREVALENCE AND RISK-FACTORS
    HUGHSON, WG
    MANN, JI
    GARROD, A
    [J]. BRITISH MEDICAL JOURNAL, 1978, 1 (6124): : 1379 - 1381
  • [7] OVERWEIGHT CATS - PREVALENCE AND RISK-FACTORS
    SCARLETT, JM
    DONOGHUE, S
    SAIDLA, J
    WILLS, J
    [J]. INTERNATIONAL JOURNAL OF OBESITY, 1994, 18 : S22 - S28
  • [8] Steroid Phobia: A Review of Prevalence, Risk Factors, and Interventions
    Contento, Marissa
    Cline, Abigail
    Russo, Marian
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (06) : 837 - 851
  • [9] Steroid Phobia: A Review of Prevalence, Risk Factors, and Interventions
    Marissa Contento
    Abigail Cline
    Marian Russo
    [J]. American Journal of Clinical Dermatology, 2021, 22 : 837 - 851
  • [10] FECAL INCONTINENCE - PREVALENCE AND RISK-FACTORS IN THE COMMUNITY
    REILLY, WT
    TALLEY, NJ
    PEMBERTON, JH
    SCHLECK, CD
    ZINSMEISTER, AR
    [J]. GASTROENTEROLOGY, 1995, 108 (04) : A32 - A32